Li Chen

ORCID: 0009-0003-8536-6270
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Botulinum Toxin and Related Neurological Disorders
  • Cardiovascular Syncope and Autonomic Disorders
  • Ophthalmology and Eye Disorders
  • Cell Adhesion Molecules Research
  • Cancer-related molecular mechanisms research
  • Natural Compounds in Disease Treatment
  • interferon and immune responses
  • Lung Cancer Treatments and Mutations
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Hearing, Cochlea, Tinnitus, Genetics
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer Mechanisms and Therapy
  • Inflammasome and immune disorders
  • Circular RNAs in diseases

Kunming University of Science and Technology
2024

First People's Hospital of Yunnan Province
2024

Second People’s Hospital of Yibin
2024

Peking University First Hospital
2007-2018

Peking University
2007-2018

Non-small cell lung cancer (NSCLC) is associated with high mortality and morbidity rates. Despite major progress of treatment NSCLC over the past few decades, prognosis advanced poor, 5-year survival rates ranging from 2 % to 13 %. Belamcanda chinensis a traditional Chinese medicine used promote blood circulation, reduce swelling, heal ulcers, disperse lumps tumors, resolve stasis. In present study, anti-proliferative pro-apoptotic effects potential mechanisms action extract (BCE) in SPC-A1...

10.1016/j.heliyon.2024.e36032 article EN cc-by-nc-nd Heliyon 2024-08-01

Objective:To analyze the audiological characteristics of female patients with X-linked Alport syndrome and to explore relationship between genotype phenotype in China. Method:The hearing data 64 females diagnosed as was reviewed analyzed. All coding exons COL4A5 genes were PCR-amplified sequenced genomic DNA, or mRNA gene RT-PCR amplified skin fibroblast. Result:The cases who accompanied by hematuria proteinuria all received pure tone audiometry acoustic immitance test. The incidence loss...

10.13201/j.issn.1001-1781.2018.16.006 article EN PubMed 2018-08-01
Coming Soon ...